Navigation Links
Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
Date:4/30/2009

ne-year limb salvage in patients with critical leg ischemia (CLI) and include third party review of results by independent core-labs.

"As one of the most robust plaque excision studies to date, DEFINITIVE LE will provide much needed guidance on the treatment of PAD using plaque excision in both above- and below-the-knee applications," said co-principal investigator Lawrence Garcia, M.D., Chief of Interventional Cardiology and Associate Director of Vascular Medicine at St. Elizabeth's Medical Center, Boston. "Furthermore, this study will potentially add new insight on the optimal management of diabetic patients in this very difficult vascular territory."

Robert Palmisano, ev3's president and chief executive officer, stated, "ev3 has committed to advancing the science of peripheral artery disease treatment with a goal of making plaque excision a frontline therapy. We believe that the additional clinical data generated by our DEFINITIVE study series will provide evidence-based guidance to aid physicians in selecting optimal treatments for their patients, facilitate broader procedure adoption and establish SilverHawk plaque excision as an indispensable tool in combating PAD, a relentlessly progressive disease."

The DEFINITIVE Clinical Study Program

The DEFINITIVE LE study represents the second study in the company's DEFINITIVE clinical study program to confirm the value of plaque excision with the SilverHawk System. A U.S. IDE study, called DEFINITIVE Ca++, is currently underway to evaluate the use of the SilverHawk-R LSC (RockHawk) Plaque Excision System and the SpiderFX(R) Embolic Protection Device in the endovascular treatment of moderate to heavily calcified peripheral artery lesions. For information about the DEFINITIVE LE study and/or to locate physicians participating in the study, contact ev3 clinical affairs by phone at (763) 398-7203 or by email at

SOURCE ev3 Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
2. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
3. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
4. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
5. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
6. Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Dont Get Their Families Vaccinated
7. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
8. Video: Answer to Curing a Failing Heart May Exist in Bodys Own Do-It-Yourself Repair Kit
9. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
10. Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs
11. Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Northstar Global Business Services, Inc., Symbol ... hard work from many talented specialists, the company ... package design.  The new formulation for Snorenz original ... product due to overwhelming evidence of increased efficacy ... will also include these vitamins, as well as ...
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Kentucky blocked the sale of ...
(Date:8/20/2014)...  The National Association of Drug Diversion Investigators ... the real-time, pseudoephedrine (PSE) blocking system in Missouri. The ... (NPLEx), automatically blocks unlawful pseudoephedrine sales and helps ... make arrests. Data released by NPLEx shows electronic ... the sale of more than 19,030 boxes of medicine ...
Breaking Medicine Technology:Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... Tissues at Well-Tolerated ... Doses, ... data from a phase 1 dose-escalation trial of XL765, a,novel small molecule ... proliferation, survival, and,resistance to chemotherapy and radiotherapy. The trial is being carried ...
... III clinical trial --, CHICAGO, May 31 ... the presentation of updated results from,a 482 patient, ... dexamethasone (VcD) to vincristine, adriamycin and,dexamethasone (VAD). Results ... in the VcD arm as induction therapy and ...
Cached Medicine Technology:Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO 2Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO 3Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO 4Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO 5VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 2VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 3VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 4VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 5VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 6
(Date:8/21/2014)... Recently, Van Uden Center has noticed ... is on the rise and much of that ... Fiscal Times, young people are becoming more accepting ... The Fiscal Times published an article on July ... medicine. The article can be found at ...
(Date:8/21/2014)... Line: Patients with advanced laryngeal cancer appear to ... surgery than nonsurgical chemoradiation. , Author: Uchechukwu C. ... Medicine at Mount Sinai, New York, and colleagues. ... laryngeal cancer are diagnosed each year and squamous ... these tumors. Prior to 1991, total surgical removal ...
(Date:8/21/2014)... the environmental source of fungal infections that have been ... literally grows on trees. , The discovery is based ... spent the summer gathering soil and tree samples from ... the fungus named Cryptococcus gattii (CRIP-to-cock-us ... number of species including C. gattii , causes ...
(Date:8/21/2014)... THURSDAY, Aug. 21, 2014 (HealthDay News) -- Not only is ... can save them hundreds of health-care dollars a year, a ... a professor of public health sciences at Wake Forest Baptist ... overweight and obese type 2 diabetes patients. ... randomly assigned to either an intensive "lifestyle change program" focused ...
(Date:8/21/2014)... Honolulu (PRWEB) August 21, 2014 ... its 10th anniversary and a national voice in ... leaders in health disparities during the 112th National ... , Distinguished honorees included: , John Ruffin, Ph.D, ... Health and Health Disparities, whose life-long career and ...
Breaking Medicine News(10 mins):Health News:Van Uden Center Sees Growth in Alternative Medicine 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2Health News:W. Montague Cobb/NMA Health Institute Honors Three Outstanding Leaders in Health Disparities 2
... -- The recently formed Mayo Clinic Center for ... the formation of the Social Media Health Network, ... promote health, improve health care and fight disease. ... platforms for sharing training materials and resources, this ...
... Against Cancer, are pioneering the use of a common curry ... the University Department of Cancer Studies and Molecular Medicine is ... undergoing surgery. The aim is use tissue from the ... extract of the commonly used root turmeric. ...
... Ill. Using incidental findings from routine diagnostic CT, radiologists ... for cardiovascular disease, according to a new study appearing online ... "The results of this study show that radiologists can predict ... the aortic wall on CT, along with minimal patient information, ...
... on how African American patients with asthma respond to ... Researchers found that improved lung function in patients after ... baseline breathing function measures, not genetic ancestry. The study ... & Clinical Immunology , http://www.aaaai.org/media/jaci/ Advances ...
... Ellin Holohan HealthDay Reporter , MONDAY, Sept. 27 ... predict stroke patients, risk of dying in the hospital and ... new Canadian study. Hospitals also can use the ... study author Dr. Eric Smith, assistant professor of neurology at ...
... American Association of Cardiovascular and Pulmonary Rehabilitation will ... Angeles Biomedical Research Institute (LA BioMed) principal investigator, ... meeting in Milwaukee. Dr. Casaburi, who holds ... Rehabilitative Sciences at LA BioMed and leads its ...
Cached Medicine News:Health News:Mayo Clinic Center for Social Media launches global Social Media Health Network 2Health News:Mayo Clinic Center for Social Media launches global Social Media Health Network 3Health News:Curry cooking ingredient could provide recipe for fight against cancer 2Health News:Researchers use CT to predict heart disease 2Health News:No link between genetic ancestry, asthma response in African-Americans 2Health News:New Tool Helps Predict Stroke Patient's Risk of Death in Hospital: Study 2Health News:New Tool Helps Predict Stroke Patient's Risk of Death in Hospital: Study 3Health News:LA BioMed researcher to receive prestigious honor 2
... Viscoelastic System is designed to give two ... can be used differently and sequentially to ... The choice of the viscoelastic is based ... of each to facilitate performance of the ...
... a product comes along that forever raises ... category. The new StealthStation TREON plus Treatment ... Built on the phenomenal success of the ... system in the worldthe new TREON plus ...
... and the FF 450plus Fundus Camera are ... of accuracy and security that can't be ... Without this level of integrated synergy, calibration ... VISUPAC system pixel for pixel, the FF ...
The new Riata® i lead family allows physicians even more versatility when managing patients with high defibrillation thresholds (DFTs)....
Medicine Products: